[Retracted] HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer

Figure 12

Correlation analyses of the HHLA2 expression with the pathway GSCA in pan-cancer. The pathway GSCA included are as follows: TSC/mTOR, RTK, RAS/MAPK, PI3K/AKT, EMT, DNA Damage Response, Cell Cycle, and Apoptosis pathways.